Claraphi Advisory Network, LLC Amarin Corp Plcuk Transaction History

Claraphi Advisory Network, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$3.64 - $7.76 $167,596 - $357,293	-46,043 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $4,780 - $8,260	1,000 Added 2.22%	46,043 $319,000
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $8,952 - $48,184	-2,238 Reduced 4.73%	45,043 $180,000
Q4 2019 Feb 13, 2020	SELL	$13.94 - $24.12 $381,482 - $660,067	-27,366 Reduced 36.66%	47,281 $1.01 Million
Q3 2019 Nov 08, 2019	SELL	$13.89 - $23.16 $4,792 - $7,990	-345 Reduced 0.46%	74,647 $1.13 Million
Q2 2019 Jul 29, 2019	BUY	$16.27 - $20.51 $184,192 - $232,193	11,321 Added 17.78%	74,992 $1.45 Million
Q1 2019 May 13, 2019	SELL	$12.61 - $22.33 $27,981 - $49,550	-2,219 Reduced 3.37%	63,671 $1.32 Million
Q4 2018 Feb 12, 2019	BUY	$12.41 - $22.98 $128,679 - $238,279	10,369 Added 18.68%	65,890 $897,000
Q3 2018 Nov 09, 2018	BUY	$2.45 - $16.27 $7,423 - $49,298	3,030 Added 5.77%	55,521 $903,000
Q2 2018 Aug 14, 2018	SELL	$2.68 - $3.48 $87,952 - $114,206	-32,818 Reduced 38.47%	52,491 $162,000
Q1 2018 May 14, 2018	BUY	$2.99 - $4.44 $220,476 - $327,396	73,738 Added 637.27%	85,309 $257,000
Q4 2017 Feb 05, 2018	BUY	$3.06 - $4.09 $35,407 - $47,325	11,571	11,571 $46,000

183

71.2M

183K

66.7K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $177M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.